Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this post-marketing surveillance study is to collect information on efficacy
and safety for prophylactic administration of zanamivir in clinical practice in family or
persons living with patients with influenza virus infection.